Kaiser Permanente Northern California Deepens Its COVID-19 Research Agenda
Division of Research investigators examine the pandemic’s effects from all angles.
Active Tuberculosis Linked To Higher Long-term Risk of Death
In a retrospective Kaiser Permanente study, people who recovered from active tuberculosis had a higher long-term risk of death from any cause than similar patients who never had active tuberculosis.
Telehealth Appointments Improve Follow-up Care in Patients with Heart Failure
Kaiser Permanente study is first to compare early telehealth approach to early in-person follow-up.
Teens, Parents, Physicians Support Screening Young People for Gender Identity, Study Suggests
Kaiser Permanente physician researchers say screening could improve care for gender diverse adolescents.
Could Heart Drug Reduce COVID-19 Risk?
Scientists at the Kaiser Permanente Northern California Division of Research started a clinical trial in August, called MITIGATE COVID-19, that will look at whether a [...]
Fewer Endometrial Cancer Diagnoses During COVID-19 Pandemic
New Kaiser Permanente study one of first to show novel coronavirus impact on cancer detection.
Early Colorectal Cancer Screening Benefits African Americans
Kaiser Permanente study supports starting screening at age 45 among this higher-risk population.
Kaiser Permanente Researchers Develop New Prostate Cancer Risk Calculator
Shared decision-making tool provides information that can help patients during prostate cancer screening.
Kaiser Permanente Researchers Present Latest Findings at Global AIDS2020 Conference Held Online
Kaiser Permanente’s rich history of research and care delivery innovation around HIV and AIDS is being highlighted at the global International AIDS Conference (AIDS2020).
On-demand HIV Prevention Pills Worked Well for San Francisco Patients
New as-needed PrEP regimen may increase use of highly effective medication, Kaiser Permanente researchers say.